Multiple sclerosis (MS) is a complex inflammatory and demyelinating disease of central nervous system (CNS). The disease pathogenesis is not fully understood and no actual cure for the disease yet. The disease has genetic and environmental cause as fundamental factors which are identified for the disease pathogenesis so far. One of the characteristic features of the disease is inflammation cause due to activation of pro-inflammatory cells. Interference in signalling pathways such as JAK/STAT could result in physiological or pathological outcome in MS. Dysregulation of JAK/STAT signalling pathway is associated with chronic inflammatory process and immune disorders. In this review, considering the important role of JAK/STAT pathway in signal transduction of inflammatory process and immune responses in CNS, we describe the involvement of this signal transduction pathway in MS. Moreover, we consider the physiological and pathological involvement of JAK/STAT rout in neurogenesis/gliogenesis, cytokines production and as therapeutics target for managing MS.
Introduction
Multiple sclerosis (MS) is an inflammatory, demyelinating, and neurodegenera-which participate in important biological processes such as cell growth, differentiation, proliferation, survival, apoptosis and immune responses [23] thus are crucial in many cell types. The discovery of this pathway, especially in the field of cell biology, gives an explanation to the mechanism of gene regulation that significantly add more information on the action of hormones, interferons, colony-stimulating factors, and interleukins [24] together with its involvement in neurogenesis [25] , glial differentiation [26] and CNS diseases [27] [28] .
Structural overview: Structurally, each molecule of JAK contains seven JAK homology domains (JH1-7). The carboxyl JH1 domain is responsible for catalytic activity, whereas N-terminal JH7 domain contains the receptor binding site (Figure 1 ). In contrast, JH1 and JH2 domains have significant homology but JH2 lacks enzymatic activity thus regarded as pseudo-kinase domain [14] . These kinases bind to the juxtamembrane region of cytokine receptors [29] . The seven 
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OALib Journal structurally and functionally mammalian STAT family have size range from 750 to 850 amino acids [30] and share conserved domains. This includes the amino-terminal domain (NH2), the coiled-coiled domain (CCD), the DNA binding domain (DBD), the linker domain and the SH2/tyrosine activation domain (Figure 1 ). In contrast, the carboxy-terminal transcriptional activation domain (TAD) differs and contributes to STAT specificity [31] . Moreover, SH2 as the most highly conserved STAT domain have the capacity to bind to specific phosphotyrosine motifs thus serve a significant role in signaling [31] .
Activation: JAK/STAT pathway receptor is activated by cytokines, hormones or growth factors resulting in dimerization of the receptor and subsequent activation of JAK and phosphorylation of tyrosine residues [13] [32] . The activated JAK recruits and phosphorylates STAT on its conserved tyrosine residue [33] .
The STAT then becomes dimerize and subsequently translocate into the nucleus where it will bind with DNA and regulate genes expression [23] (Figure 1 ). In contrast to other STATs, STAT5A/B are specifically activated in response to a variety of cytokines as well as tyrosine kinase receptors and were plausibly assumed that they have a basic role in cell growth regulation [35] [36] . Of note the STAT activation by non-cytokine receptor can be JAK-dependent or JAK independent however, it varies depends on receptors [23] .
JAK/STAT Pathways Involvement in Neurogenesis/Gliogenesis
During proliferation and differentiation of brain cells, neural stem cells (NSC) or neural progenitor cells (NPC) mostly differentiate into neurons, astrocytes or oligodendrocytes in sub ventricular zone (SVZ) of olfactory bubs and dentate gyrus (DG) of the hippocampus of adult brain [37] . JAK/STAT pathway is associated with regulation of NSC proliferation. Adult NSC of the SVZ expresses IL-15 which plays role in activation of STAT1, 3 and 5, and NSCs proliferation which could be blocked by JAK inhibitors [38] [39]. JAK1 is probably involved in astrocytic differentiation [40] , whereas, JAK2 seems more important for NSC proliferation [41] while JAK3 is reported to induce neuronal and oligodendroglial differentiation in NSCs [42] . Both in vitro and in vivo studies showed that activation of STAT3 and Akt by leptin results in regulation of neuroproliferation in the DG of adult mice [41] . Moreover in adult's DG, neurogenesis is reported to rely on STAT3 activation [43] . Interferon β, typically used in treatment of MS, can activate STATs [13] thus implicated in controversial role in proliferation and differentiation of NPC in murine [44] , because it can either inhibit [45] , have no effect [44] or enhance the proliferation of the NPC [46] . Previous study on the role of JAK-STAT in glial differentiation showed that activation of ciliary neurotrophic factor (CNTF) receptor is associated with activation of JAK1, STAT1 and STAT3 and stimulating the differentiation of embryonic cortical precursor cells into astrocytes [13] . Similarly JAK2, STAT1 and STAT3 activation is partly associated with proliferation and differentiation of astrocytes [47] .
Moreover, a study showed that STAT3 knock-down mice enhanced neurogene-
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OALib Journal sis while blocking astrogliogenesis [25] . Inhibitory proteins of JAK-STAT pathway such as SOCS 2, 3 and 6 negatively regulate neuronal differentiation and neurite outgrowth after induction of insulin-like growth factor-1 (IGF-1) and growth hormone [48] . Previous study on SOCS2 knock out mice reported that overexpression of SOCS2 can blocks GH-signalling and impairs neurogenesis, whereas neuronal differentiation was increased [42] .
STAT activation could lead to apoptosis [13] , for example IFN-γ activation of STAT1 affects NPCs by reducing its proliferation and inducing apoptosis via upregulation of p21 and caspase-3 signaling [49] . Rather IL-9 signaling protects neonatal neurons from apoptosis by activation of the JAK-STAT pathway [50] .
Moreover, a study showed that in vitro treatment of IL-9 and AG490 activate STAT1 and STAT3, however this anti-apoptotic effect could be obstructed by possible inhibitor of JAK-STAT pathway in vivo [50] . Furthermore, STAT3 and STAT 5 are more anti-apoptotic than STAT1 [30] . However, the proportion of STAT1 activation over that of STAT3 and STAT5 seems to play a role in apoptosis [30] . JAK-STAT pathway plays a role in neuronal regeneration and glia scar formation around the lesion after injury to CNS [13] (Figure 2 ). In this regard Figure 2 . JAK/STAT involvement in MS. Activation of JAK/STAT pathway results in physiological or pathological process. Physiologically the pathway was involved in neurogenesis/gliogenesis; this process has a positive impact on MS/EAE as it supports processes such as axonal regeneration that will ameliorate MS condition. Cytokines involvement due to activation of this pathway result in pro-or anti-inflammatory processes. The differentiation of proinflammatory cells has negative consequences on MS/EAE as it exacerbate the condition, whereas the differentiation of anti-inflammatory cells and its cytokines favors amelioration of MS/EAE conditions thus have positive effect. JAK/STAT pathway serves as therapeutic target for amelioration of MS/EAE conditions. The pathway, proinflammatory cytokines and differentiation of Th1 and Th17 could be block by inhibitory compound and leads to inhibition of proinflammatory processes.
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OALib Journal STAT3 was found to be overexpressed and activated in regenerating neurons following injury to axon [51] . Previous study on adult mouse reported axon regeneration occurs after deletion of SOCS3 [52] and SOCS3 is a potent inhibitor of the pathways. After CNS injury astrogliosis rely on STAT3 activation [28] . Inhibition of STAT3 activation via JAK2 inhibition using AG490 on the proximal nerve stump can reduce neurite outgrowth [53] .
JAK/STAT Pathway and Cytokines in MS
Cytokines are important in activation and regulation of immune mechanisms and inflammatory responses [24] . Cytokine networks exert their pro-and anti-inflammatory effects through multiple downstream signaling pathways [54] .
In this regard, the JAK-STAT signaling pathways are involved in the signaling of several of pro-and anti-inflammatory cytokines (Table 1 ). In pathological condition members of JAK/STAT with complementary or antagonistic effects are often activated simultaneously [34] . Moreover, a study showed that STATs activation was significantly increased in brain and spinal cord of experimental autoimmune encephalitis (EAE) mice than in healthy control mice [55] . EAE is the animal model of MS.
STAT1 induces the activation of Th1 and IFN-γ cytokines which have an essential role in inflammatory disease in the CNS [56] . STAT1 is required for development of Th1 cells, which are associated with proinflammatory processes [57] . Furthermore, STAT5A/B increases Th1 responses by regulating T-box transcription factor (TBX21) and interleukin-12 receptor subunit beta-2 (IL12Rβ2) [58] . Interestingly, STAT3 takes part in Th2 differentiation and binds to Th2-associated gene loci [59] .
In MS IFN-γ and IL-6 were detected in higher levels in target tissues and they exert their effects via the activation of STAT1 and STAT3, respectively [34] .
Moreover, IL-6 promotes Th17 and B cell differentiation [60] , whereas, IFN-γ induced JAK1/2-STAT1 signaling effect which was observed in classically-activated macrophages [61] IL-27 JAK1/STAT-3 Treg IL-10, TGFRβ1 [34] JAK/STAT4 and NF-κB play important role in the pathways involved in pro-inflammatory processes [54] . Activation of the NF-κB transcription factor results in production of proinflammatory cytokines, nitric oxide (NO) and secretion of chemokines by macrophages, whereas on Dendritic cells there is increase expression of CD83, CD86, and CD40, as well as MHC class II [64] which could be important in MS pathogenesis. A study by Jiang and co-workers reported significant upregulation of JAK/STAT4 and NF-κB signaling pathways in EAE [65] . However, STAT4 knockout mice failed to develop EAE [66] , this suggests STAT4 pathway could be irrelevant in EAE. However, CD4/STAT3 knockout mice are resistant to EAE, this shows the important role of STAT3 pathway in CNS inflammatory diseases [57] . . In a brain, these cytokines induce inflammation which is characterized by infiltration of neutrophil into CNS and myelin loss [69] . High levels of IL-17 in MS lesion are associated with strong inflammatory response which could lead to exacerbations of the disease [70] . The IL-17-producing T cells (CD4+ or CD8+) have been detected in both acute and chronic MS [71] . Therefore, various studies linked this cytokine with autoimmune and chronic inflammatory conditions [72] . For instance, a study on IL-17 knockout mice shows a significant reduction in severity of EAE;
this denotes the important role of this cytokine in EAE pathogenesis [72] .
Moreover, the upregulation of IL-10 by immunoregulatory cytokines IL-27, suppresses IL-17, this action ultimately suppresses EAE [73] . Both Th1 and Th17 cells responses are required for EAE development [74] . IL-6/STAT3 pathway was identified as regulators of Th17 cells differentiation and function by increasing the expression and activation of the IL-6 itself, IL-17 and STAT3 [75] .
IL-2/STAT5A/B signalling pathway regulates Th17 differentiation [76] by competing with STAT3 in binding to the IL17A/F locus [77] . STAT3 directly binds to IL17A/F, RAR-related orphan receptor C (RORC) and interleukin-23 receptor (IL23R) and some genes involved in Th17 differentiation to influence the regulation of the differentiation [78] . 
JAK/STAT Pathway as Therapeutic Target in MS
The pathway has received attention as a therapeutic target in autoimmune dis-K. M. Hamid et al.
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OALib Journal eases [17] [24] [83] . Many of the MS-promoting cytokines such as IL-1β, TNF-α and especially that of IL-6 and IL-12 either signal through or induce JAK/STAT signaling molecules [84] . Studies have implicated the JAK/STAT axis in regulating clinical manifestations of EAE [85] . JAK inhibitors produced promising result in some inflammatory diseases [86] [87] . JAK inhibitors interrupt cytokine signaling; consequently, break the inflammatory process, a useful process in MS and EAE [85] (Figure 2) . Indeed, previous study reported tyrphostin B42, a JAK2 inhibitor; ameliorate EAE [84] . A study found that AZD1480 treatment is effective in suppressing clinical symptoms in EAE. Similarly Peroxisome proliferator activated receptor-γ (PPARγ) and Cyclooxygenase 2 (COX2) inhibitors block the activation of JAK/STAT pathway to some extent by IL-12 thus will be able to ameliorate EAE condition [88] . In a Study using AG490 to inhibit the action of JAK2 and TYK2 as treatment of EAE showed a decrease in the activity of Th1, NK and microglial cells and reduces IL-12 levels [84] . Plumbagin (PL) and berberine are herbal compounds which inhibit the activation of JAK-STAT pathway and Th1 and Th17 cell differentiation thus prevent exacerbation of EAE model [89] [90] . Similarly, in EAE, glatiramer acetate (GA) to some extent inhibits the phosphorylation of STAT4 and STAT3 in T-cells thus exerts some effect on Th1 and Th17 cell differentiation, respectively [91] . IFN-β action in treatment of MS requires the activity of JAK1 to activate phosphoinositide 3-kinase (PI3K) and protein kinase B (PKB), this result in repression of glycogen synthase kinase-3 beta (GSK3β) activity in EAE [92] . Researches related to JAK/STAT and MS need good attention and concern, considering the complex nature of the disease and its treatment.
Conclusion
